Markets:

Overview

News

Currencies

International

Treasuries

Alumis Inc. - Common Stock (NQ:ALMS)

19.56 +1.38 (+7.59%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alumis Inc. - Common Stock

< Previous 1 2 3 Next >

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

January 08, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗

January 08, 2026

Nvidia, Apple, Microsoft, and select biotech names dominated early market buzz.

Via Stocktwits

Topics ETFs Government Stocks

Unusual volume stocks in Wednesday's session ↗

January 07, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗

January 07, 2026

Via Stocktwits

Topics Stocks

Dow Clears 49,000 as AI’s “Data Deluge” Ignites a Memory-Stock Melt-Up ↗

January 07, 2026

Via Chartmill

Topics Artificial Intelligence Stocks

Alumis Stock Hits Record High As Wall Street Cheers Phase 3 Psoriasis ‘Win’ — Analysts See Best-In-Class Potential ↗

January 06, 2026

The company also disclosed plans of a $175 million underwritten share offering after releasing its Phase 3 trial data.

Via Stocktwits

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗

January 06, 2026

Investors today are cheering envudeucitinib's Phase 3 edge in oral TYK2 psoriasis as well as Alumis' plans to raise fresh capital.

Via The Motley Fool

Topics Stocks

The Great Rotation: Small-Caps Lead 2026 Market Charge as Tech Giants Stumble

January 06, 2026

The first week of 2026 has delivered a definitive verdict on the next phase of the bull market: the era of mega-cap dominance is yielding to the rise of the small-cap. In a dramatic "Great Rotation,"...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why

January 06, 2026

Via AB Newswire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 06, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

January 06, 2026

Via Chartmill

Why Is ALMS Stock Rising Today? ↗

January 06, 2026

Alumis announced positive results from both of its Phase 3 clinical trials of envudeucitinib.

Via Stocktwits

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 06, 2026

Via Chartmill

Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program

January 06, 2026

From Alumis Inc.

Via GlobeNewswire

Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗

January 06, 2026

Markets seem to be balancing CES-driven AI optimism with caution ahead of upcoming jobs data.

Via Stocktwits

Topics Artificial Intelligence ETFs Stocks

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗

December 29, 2025

A full exit during a volatile stretch raises a sharper question than timing alone.

Via The Motley Fool

What's going on in today's session ↗

December 05, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗

December 05, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Amer Sports Posts Upbeat Q3 Earnings, Joins Diginex, James Hardie Industries And Other Big Stocks Moving Higher On Tuesday ↗

November 18, 2025

Via Benzinga

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 20, 2025

Via Benzinga

Alumis Misses Q2 Revenue as Costs Jump ↗

August 13, 2025

Via The Motley Fool

Top movers in Tuesday's session ↗

May 20, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 20, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 20, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

May 13, 2025

From ACELYRIN, INC.

Via GlobeNewswire

Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis

May 06, 2025

ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today

From ACELYRIN, INC.

Via GlobeNewswire

ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis

May 01, 2025

From ACELYRIN, INC.

Via GlobeNewswire

Charles Schwab To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

April 22, 2025

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.